1. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial;Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium;Lancet,2019
2. Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study)
3. World Health Organization. New study finds no link between HIV infection and contraceptive methods. 2019. https://www.who.int/reproductivehealth/hc-hiv/en/
4. World Health Organization. Contraceptive eligibility for women at high risk of HIV. Guidance statement: recommendations on contraceptive methods used by women at high risk of HIV. 2019. https://www.who.int/reproductivehealth/publications/contraceptive-eligibility-women-at-high-risk-of-HIV/en/